672-46-8 Usage
Uses
Used in Pharmaceutical Industry:
4,6-Diamino-2-trifluoromethylpyrimidine is used as a pharmaceutical intermediate for the development of new drugs. Its unique chemical structure allows it to be a promising candidate for the synthesis of various therapeutic agents, potentially leading to the discovery of novel treatments for a range of diseases.
Used in Agrochemical Industry:
In the agrochemical industry, 4,6-Diamino-2-trifluoromethylpyrimidine is used as a building block for the synthesis of agrochemicals. Its potential inhibitory effects on certain biological processes make it a valuable component in the development of new pesticides, herbicides, and other agricultural chemicals.
Used in Organic Synthesis:
4,6-Diamino-2-trifluoromethylpyrimidine is utilized as a versatile building block in organic synthesis. Its unique structure and properties enable chemists to create a variety of new compounds with potential applications in various industries, such as materials science, pharmaceuticals, and agrochemicals.
Overall, 4,6-Diamino-2-trifluoromethylpyrimidine is a chemical compound with a wide range of potential applications, making it a valuable asset in the fields of pharmaceuticals, agrochemicals, and organic synthesis. Its unique structure and properties offer opportunities for the development of innovative products and solutions.
Check Digit Verification of cas no
The CAS Registry Mumber 672-46-8 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 6,7 and 2 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 672-46:
(5*6)+(4*7)+(3*2)+(2*4)+(1*6)=78
78 % 10 = 8
So 672-46-8 is a valid CAS Registry Number.
InChI:InChI=1/C5H5F3N4/c6-5(7,8)4-11-2(9)1-3(10)12-4/h1H,(H4,9,10,11,12)
672-46-8Relevant academic research and scientific papers
PqsR INVERSE AGONISTS
-
Page/Page column 56; 57, (2020/01/31)
The present invention relates to a compound according to general formula (I), which acts as an inhibitor of PqsR (the currently only known receptor for the Pseudomonas Quinolone Signal (PQS)); to a pharmaceutical composition containing one or more of the compound(s) of the invention; to a combination preparation containing at least one compound of the invention and at least one further active pharmaceutical ingredient; and to uses of said compound(s), including the use as a medicament, e.g. the use in the treatment or prophylaxis of a bacterial infection, especially a Pseudomonas aeruginosa or Burkholderia infection.
